Marpai, Inc., an independent national Third-Party Administration (TPA) company transforming the $150 billion TPA market, has officially announced the re-launch of MarpaiRx, which happens to be a groundbreaking pharmacy benefit management solution, which happens to be a solution geared towards delivering superior member experiences, as well as achieving significant cost reductions for health plans.
According to certain reports, MarpaiRx arrives on the scene bearing an ability to offer complete transparency, as it contains no hidden spreads, no surprise markups, and at the same time, offers real savings for health plans and members.
Talk about the whole value proposition on a slightly deeper level, we begin from the promise of industry’s lowest net cost approach. This translates to how MarpaiRx’s underlying technology treads up a long distance to reach upon the most cost-effective, clinically appropriate medications for each member, every time.
Next up, we have superior member experience coming into play. You see, thanks to MarpaiRx, users can effectively streamline Rx delivery, prior authorizations, financial assistance coordination, and more, to make the pharmacy experience hassle-free.
Another detail worth a mention relates to how the new technology delivers at your disposal a flexible pharmacy network, something which it achieves after searching a vast network of pharmacies to achieve the absolute best price on every prescription.
Then, there is the prospect of integrated patient assistance. As a result; Maripai’s specialized works rather tirelessly to enroll eligible members in manufacturer copay assistance programs.
MarpaiRx also brings forth a facility for international sourcing. Applicable in the case of selected medications, the solution in question can seamlessly leverage international sourcing to secure significant discounts, while simultaneously maintaining supply chain integrity.
Moving on to the potential for real-time optimization, it ensures that prescriptions are analyzed in real-time so to identify the lowest net cost option and automatically apply relevant assistance programs.
Joining that would be the availability of actionable insights. With these sophisticated data analytics, MarpaiRx can provide user continuous monitoring of utilization, identify further savings opportunities, and empower them to make informed decisions.
Rounding up highlights would be feature focused on deploying an assortment of APIs that allow for integration with existing health IT systems, fostering a holistic view of member health.
Founded in 2019, Maripai’s rise up the ranks stems from dispatching TPA and value-oriented health plan services to employers that directly pay for employee health benefits. Operating in an space worth around $150 billion, the company offers access, at the moment, leading provider networks including Aetna and Cigna and all TPA services.
“According to a 2024 study by America’s Health Insurance Plans (AHIP), over 24% of each healthcare dollar is spent on prescription drugs. The Company’s mission is to empower health plans to provide the best possible pharmacy benefits for their members at the most affordable cost,” said Dallas Scrip, Chief Operating Officer of Marpai. “MarpaiRx achieves this through a unique combination of advanced technology, a focus on lowest net cost, and a commitment to member experience.”
